What a stool test actually shows you

Patients come in with the same set of complaints almost every week: bloating that doesn’t track with what they ate, reflux that comes and goes, stools that don’t look the way they used to, the post-meal crash that makes the afternoon a negotiation. They have usually had a colonoscopy. The colonoscopy was clean. They were told they have IBS, given a diet sheet, and sent on.

A clean colonoscopy is good information — it rules out cancer, rules out structural disease, rules out polyps. It is not a read of how the gut is functioning. The questions a colonoscopy answers are not the questions most of my patients are actually asking.

What a comprehensive stool test reads that your GI’s panel doesn’t

The GI-MAP panel I order in clinic is a DNA-based stool test that reads four things at once. None of them are visible on a colonoscopy, and none of them show up on a basic ova-and-parasite screen:

• The microbiome itself— which commensal bacteria are present, in what proportions, and which keystone species (Akkermansia, Faecalibacterium, the butyrate-producers) are missing. Dysbiosis isn’t one bug; it’s a community out of balance.
• Pathogens and overgrowth — H. pylori (with virulence factors), C. difficile, E. coli, Salmonella, Shigella, parasites (Giardia, Blastocystis, Entamoeba), and yeast (Candida) at quantitative levels rather than just present/absent.
• Digestive function and inflammation — pancreatic elastase (do you actually digest fats and proteins), steatocrit (fat in stool), beta-glucuronidase (gut-driven hormone recirculation), secretory IgA (mucosal immunity), and calprotectin (the inflammation marker that distinguishes IBS from inflammatory bowel disease).
• Intestinal permeability— zonulin, the tight-junction regulator. This is the marker behind “leaky gut,” which a few years ago was a fringe term and is now in the mainstream literature on autoimmunity, food sensitivity, and neuroinflammation.

Why this matters for the patient who has “tried everything”

A patient who has cycled through proton-pump inhibitors, low-FODMAP, probiotics from the grocery aisle, and three different elimination diets without lasting relief is usually dealing with one of a small number of patterns:

• An undiagnosed pathogen — H. pylori or a parasite that no one has looked for since the standard screen missed it.
• Bacterial overgrowth or dysbiosis — too much of the wrong species, too little of the right ones, often downstream of a single course of antibiotics years ago.
• A digestion problem, not a microbiome problem — low pancreatic output, low stomach acid, or insufficient bile flow. Symptoms feel like the gut, but the lever is upstream.
• Leaky gut feeding a wider system — autoimmune flares, joint pain, brain fog, migraines, skin rashes that the patient never connected to their digestion.

You cannot tell which of these is going on by guessing. You also cannot fix all of them with the same protocol. The reason a comprehensive stool test pays for itself is that it converts “something is wrong with my gut” into a specific question with a specific answer.

How I actually read a GI-MAP

The first thing I look at is not the pathogen panel — it is the digestive function block. If pancreatic elastase is low and steatocrit is high, the patient is not absorbing what they eat, and no amount of probiotic is going to fix that. Then I look at the keystone species: are they present at all, are they suppressed, are the butyrate-producers low (which predicts colon-lining repair). Only then do I read the pathogen and overgrowth panel, because the same Candida finding means a different thing in a patient with intact secretory IgA than in a patient whose mucosal immunity has collapsed.

The plan we build from a GI-MAP is sequenced. We do not throw binders, antimicrobials, and probiotics at the gut at once. Most patients are looking at three to four months of real work — kill (where indicated), restore digestive output, reseed the microbiome, repair the lining. The order matters. Compressing it tends to backfire.

Who this test is — and isn’t — for

Right fit:chronic bloating, IBS that hasn’t responded to diet alone, recurrent SIBO, post-antibiotic gut, suspected parasites or H. pylori, autoimmune disease where you want to read the gut driver, food reactions that have been widening, chronic constipation or diarrhea, brain fog or skin rashes that started with a gut event, or any patient whose colonoscopy and bloodwork came back clean and who is still not well.

Not the right starting point: acute abdominal pain (ER), suspected appendicitis or obstruction (imaging), suspected inflammatory bowel disease (the colonoscopy is still the right call), or a patient who has not yet trialed basic dietary and lifestyle changes. The GI-MAP is a precision tool for the patient who has run out of obvious answers, not a first-line screen for someone who is otherwise well.

We don’t mask symptoms — we look to address the underlying issues that cause symptoms and disease. Most chronic conditions touch the gut. The stool test is how we actually look.

If you have been told everything is normal and your gut still doesn’t feel normal, the gap between those two sentences is almost always sitting in the part of the panel no one ran. The GI-MAP runs it.

The journal is written by Dr. Nazzar from the practice. Articles reflect clinical observation and current research, not personalized medical advice. To explore your own case, schedule a consultation.